HLA-C and non-small cell lung carcinoma: In line with this evidence and as NSCLC might block the expression of HLA class I molecules to escape immune surveillance, potential immunomodulatory and MHC-encoding genes overexpressed in NSCLC and COPD have been studied as promising biomarkers of responses to immunotherapy [113,114,115,116,117,118].